Reason: cervical cancer, radiation brachytherapy planningAdditional history per electronic medical record:Stage IIIB squamous cell carcinoma of cervix, s/p 6 cycles Carbo/Taxol/Avastin, and soon will complete EBRT with concurrent Cisplatin. PELVIS:UTERUS, ADNEXA: The uterine body is small in size, decreased from prior outside examination and which is favored to reflect atrophy in the absence of surgical history of supracervical hysterectomy.The ovaries are normal in size for age. No adnexal masses are identified.There is heterogeneous, abnormal soft tissue signal in the region of the cervix (series 3, image 32) measuring approximately 1.8 x 3.7 cm in the axial plane extending from approximately the level of the left UVJ inferiorly into the uterine body. There is associated heterogeneously increased enhancement. There is also restricted diffusion at the level of the cervix. The area of abnormal signal abuts the posterior wall of the bladder without frank evidence of invasion. The area of abnormal signal also surrounds the distal left ureter at the left ureterovesical junction.BLADDER: The distal tip of a nephroureteral stent is partially visualized in the bladder.LYMPH NODES: No pelvic lymphadenopathy is identified.BOWEL, MESENTERY: No significant abnormality noted.BONES, SOFT TISSUES: No significant abnormality noted.OTHER: No significant abnormality noted.
Abnormal signal intensity involving the cervix extending into the uterine body compatible with cervical neoplasm as described above. No pelvic lymphadenopathy.